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MYTHS OF THE MEDICAL METHODS EXCLUSION: MEDICINE AND PATENTS IN 
NINETEENTH CENTURY BRITAIN 
Robert Burrell* and Catherine Kelly** 
 
RA  
I. INTRODUCTION 
This article explores the interaction of British medical practitioners with the nascent 
intellectual property system in the nineteenth century. It challenges the generally accepted 
view that throughout the nineteenth century there was a settled or professionally agreed 
hostility to patenting and to the patenting of methods of medical treatment in particular. We 
demonstrate that a significant number of medical practitioners did seek to patent their 
inventions, including some methods of medical treatment, while others made use of closely 
related alternatives, in particular, the utility designs regime. Admittedly the number of 
applications remained much lower than in other fields of technical endeavour. But the failure 
of medical practitioners to establish a strong culture of patenting during the nineteenth 
century can be explained on more prosaic grounds than the traditional narrative would have 
us believe. Specifically, we argue there was an incompatibility between the inventive process 
in medicine and the internal requirements of patent law. This incompatibility applied to many 
forms of medical advance, but was particularly acute in the case of methods of medical (and 
surgical) treatment. When, towards the end of the nineteenth century, an ethical norm about 
the inappropriateness of patenting medical advances generally, and methods in particular, 
began to coalesce, this is to be attributed in no small part to the medical profession making a 
virtue out of necessity.  
This article thus seeks to retell the history of the exclusion of medical methods from 
patent protection, an exclusion that remains widespread in patent laws around the world and 
an exclusion whose history has produced a substantial body of scholarship. However, the 
DUWLFOH¶Vaims go beyond this. It also seeks to illuminate how medical practitioners engaged 
with the broader political and policy landscape in order to secure financial remuneration for 
their inventions. In the early nineteenth century, the (practical) difficulties that medical 
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practitioners faced in using patents to secure a return for their inventive efforts led some to 
appeal to Parliament for assistance. In so doing medical practitioners were seeking to take 
advantage of a system of state rewards for inventions that had been an established feature of 
the legal landscape for many decades.1 The interactions between medical practitioners and 
Parliament around claims for rewards are interesting at a number of levels. The appeals of 
medical practitioners required Parliament to confront both the legal and policy limitations of 
the still developing patent regime. Parliament was forced to acknowledge that there were 
some forms of innovation that could not be patented. It was also clear that some innovations 
were of such social significance that it would be undesirable to grant a period of patent 
monopoly. Equally, Parliament did not want inventors to eschew the patent system and keep 
the innovation secret in the hopes of financial gain. More positively, the lobbying of medical 
SUDFWLWLRQHUVSURYRNHG3DUOLDPHQWDU\GHEDWHRQWKH6WDWH¶VUROHLQUHZDUGLQJLQQRYDWLRQDQG
VLJQLILFDQWO\WKH6WDWH¶VUROHLQHQGRUVLQJDQGSURPRWLQJPHGLFDOGLVFRYHULHV  
 
II. HOSTILITY TO PATENTING AND THE EXCLUSION OF MEDICAL METHODS 
FROM PROTECTION 
The generally accepted narrative in existing legal and medical histories and case law is that 
the nineteenth century medical profession was opposed to patenting of medical discoveries. 
The genesis of this position is said to be found in the desire of doctors to separate themselves 
in the public mind from the commercialism and opportunism of the vendors of patent 
medicines. This opposition is understood to have led to a particular consensus within the 
medical profession during the nineteenth century that it would be unethical for a medical 
practitioner to seek to patent a method of medical treatment. As regards this more specific 
claim, the legal histories invariably take the case of 5H &	 :¶V $SSOLFDWLRQ as their entry 
point.2 That case concerned a means of using electricity to remove lead from the human body 
in cases of lead poisoning. Importantly, the patent did not claim a new medical device (such 
devices could be patented ± a point to which we will have cause to return), but rather the 
method per se. Considering this method, Solicitor General Buckmaster concluded that the 
VXEMHFW RI WKH FODLP FRXOG QRW EH DVVRFLDWHG ZLWK WKH PDQXIDFWXUH RU VDOH RI D µYHQGLEOH
product' and hence FRXOGQRWEHDµPDQQHURIPDQXIDFWXUH¶DVUHTXLUHGE\V 6 of the Statute 
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of Monopolies.3 The judgment is very short, but includes a statement indicating Buckmaster¶V 
approval of the medical profession¶V opposition to the patenting of discoveries µintended to 
alleviate human suffering¶. Despite this, Buckmaster stated explicitly that in reaching his 
GHFLVLRQ KH KDG H[FOXGHG FRQVLGHUDWLRQ RI WKH SURIHVVLRQ¶V YLHZV when reaching his 
conclusion.4 
Judges and academics hDYHIRXQG%XFNPDVWHU¶VUDWLRQDOHelusive.5 It has been argued 
persuasively that GHVSLWH %XFNPDVWHU¶V GHQLDO the decision can only be understood as 
motivated by policy considerations, including the desire to uphold the PHGLFDOSURIHVVLRQ¶V
ethical position he represents it in the judgment.6 Although the soundness of the outcome has 
been questioned in subsequent cases,7 it has proved enormously powerful and is reflected in 
the law of most Commonwealth jurisdictions.8 An exclusion to much the same effect is 
incorporated in the European Patent Convention.9 Under the TRIPS Agreement, despite the 
general obligation to make patents availablHµLQDOOILHOGVRIWHFKQRORJ\¶10 Member States are 
free to exclude from SDWHQWDELOLW\ µGLDJQRVWLF WKHUDSHXWLF DQG VXUJLFDO PHWKRGV IRU WKH
treatment of humans or animals.¶11  
Academic comment and legal histories also reflect this understanding. Common to 
most judicial and academic discussion of the Methods of Medical Treatment Exclusion 
µMME¶ is an implicit acceptance that the medical profession has long been ethically 
opposed to the patenting of medical and surgical methods and the monopolization of medical 
innovation more generally. The few legal historians who have considered this and delved 
back into the nineteenth century generally concur that the medical profession had set itself 
against patenting because doctors wanted to distinguish themselves from the vendors of 
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patent medicines.12 This scholarship draws on older scholarship in the history of science that 
set the commercial emphasis of patents against a gentlemanly ideal in medicine.13 
Tina Piper, the leading legal historian on this issue, extends the argument to claim that 
LWZDVLQWKHLQWHUHVWRIGRFWRUV¶professionalising project in the later 1800s to exclude legal 
regulation ± including the patent system ± from medicine.14 She argues elsewhere that the 
immediate and ongoing authority of the MME lies in its acceptance by the mixed legal and 
professional communities receiving the law, owing to its resonance with the ethical identity 
they came to embrace as a professional attribute.15 While such claims about a widespread 
professional or ethical position may be applicable in the twentieth century, we question the 
existence of a similar culture in the century prior to C&W.  
 
III. THE ETHICS AND THE ECONOMICS OF NINETEENTH CENTURY MEDICINE 
It is now generally accepted that the early years of the nineteenth century marked one of the 
key periods in the development of the modern patent system. This is not so much because this 
was a period of great legislative or judicial advance, but rather because it was at this point 
that the patent system came into more general use, with significant and sustained increases in 
the number of patent applications. At this time the cult of the µheroic inventor¶ started to gain 
momentum in Britain and the availability of the patent system become more widely known 
outside the metropolis.16 Coincidentally, this was also a period of growth, change, and 
innovation in British medicine.17 During the French Revolutionary and Napoleonic Wars 
(1793-1815) the numbers of medical practitioners increased significantly and the exigencies 
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of war stimulated medical innovation and the promotion of new approaches to medicine. The 
end of the Wars saw a huge influx of demobilized practitioners enter the domestic market 
bringing with them the practices they had learned on service.18 The suddenly increased 
numbers squeezed the medical marketplace and created an economically challenging period 
for most doctors. Facing market realities, many struggled to make a living ± a situation which 
persisted throughout much of the nineteenth century for all but the elite of the profession.19 
These conditions would seem to have been ideal for the flourishing of a system that could 
guarantee the financial benefits of a monopoly. And yet, despite the climate of revolution and 
innovation in medicine, evidence found to date appeared to show that medical practitioners 
were hesitant to patent their innovations. 7KLV VHFWLRQ H[DPLQHV DUJXPHQWV IRU DQ µHWKLFDO¶
explanation for this hesitance and concludes that there is no strong evidence of a settled 
professional opposition to patenting or commercialized practice.  
Understanding the historical position of the medical profession on patenting is 
complicated by WKH YRFLIHURXV RSSRVLWLRQ WR µSDWHQW PHGLFLQHV¶ WKDW ZHUH D FDWFK-cry for 
many orthodox practitioners by the turn of the twentieth century. For many the confusion 
begins with the name ± in fact, patent medicines were rarely patented and the generic 
GHVFULSWRU VWRRG DV VKRUWKDQG IRU µVHFUHW UHFLSH¶ As described above, scholarship on this 
issue has contributed to a received view that medical practitioners embraced an ethical 
position opposed to consumerism, seeking to separate themselves in the market from 
µTXDFNV¶ who often sold patent medicines. While this view must have some merit, close 
examination of the question ± both on patent medicines, and on homogeneity of ethical 
perspective in the profession more generally ± shows it is implausible that this provides the 
only, or even the most compelling, explanation for the failure of most medical practitioners to 
seek patent protection for improvements in treatment.   
Support for the argument that the early medical profession had a strong ethical 
position opposed to patents at first seems to be found in 7KRPDV3HUFLYDO¶VMedical Ethics 
written in 1803 which stated: 
No physician or surgeon should dispense a secret nostrum, whether it be his 
invention, or exclusive property. For if it be of real efficacy, the concealment of it is 
inconsistent with beneficence and professional liberality. And if mystery alone give it 
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value and importance, such craft implies either disgraceful ignorance, or fraudulent 
avarice.20 
However, this ethical injunction needs to be viewed in the context of the early to mid-
nineteenth century when delineation between orthodox and quack medicine was not clear, 
and patent medicines occupied a prominent place even in the medical practice of physicians 
and surgeons who held themselves out as classically trained and formally qualified.21 
3HUFLYDO¶VNH\PHVVDJHFRQFHUQVWKHHIILFDF\RUVDIHW\RIsecret nostrums -  as we know, the 
process of patenting requires public disclosure. Further, the potential for a medicine to be the 
µH[FOXVLYH SURSHUW\¶ RI D GRFWRU LV FOHDUO\ FRQWHPSODWHG Elite medical practitioners like 
Percival were concerned with the poor quDOLW\RIµsecret nostrums¶not the commercial ethics 
of patenting.22 $V7LQD3LSHUKDVQRWHGµthere is no evidence that this nascent medical profession 
had any interest or engaged in debates over a medical exclusion from patentability¶,23 Accordingly, 
hostility to patent medicines must be understood in the context of a diverse medical 
marketplace and not conflated with medical patents.24 Further, elite views on secret nostrums 
should not be uncritically applied to the question of patentability or commercialism in 
medicine more generally  
Thus, in the first half of the century when the professional project of doctors was not 
\HWXQGHUZD\WKHH[LVWHQFHRIµSDWHQWPHGLFLQHV¶GRHVQRWRIIHUDn explanation for the failure 
of medical professionals to avail themselves of the patent system for their innovations. In the 
second half of the century a coherent and organised medical profession emerged. Hostility to 
patent medicines persisted and by the 1860s was the subject of a sustained campaign by the 
BMA, and was to an extent, twinned with an opposition to commercialism. However, even in 
this later period this does not point to a widely held ethical position opposed to patenting 
medical treatments. 
By 1860, concerns about patent medicines were expressed through a campaign of 
organised opposition using the rhetoric of public safety. This became a distinguishing feature 
of PHGLFLQH¶VSURIHVVLRQDOproject in Britain. It was especially evident in the final years of the 
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FHQWXU\ ZKHQ µDQ XQSUHFHGHQWHG DVVRUWPHnt of mass-produced and mass-marketed patent 
PHGLFLQHVIORRGHGWKHPDUNHW¶25 However, investigations of the actual practice of doctors in 
relation to patent medicines have provided clear evidence of an unsettled ethical position 
even on patent medicines within the profession. Historians who have investigated the practice 
of medical professionals across the nineteenth century have demonstrated that while 
VWDWHPHQWV OLNH3HUFLYDO¶VMedical Ethics can tell us to what some sectors of the profession 
aspired, they are not a good indicator of widespread contemporary practice. Close analysis of 
idealistic rhetoric denouncing commercialism and patent medicines, and comparison with the 
actual day-to-day activity of medical practitioners has revealed significant discrepancy.26  
Peter Bartrip has shown through analysis of advertisements in the British Medical 
Journal that ethical standards, as statements of ideals, did not always conform to prevailing 
practice. Concurrent with the resolution of the BMA Central Ethical Committee in 1903 
denouncing patents, and alongside editorials criticising those same remedies, the pages of the 
British Medical Journal LQ WKHHDUO\¶Vwere covered in advertisements for proprietary 
drugs.27 Lori Loeb has taken this analysis further and demonstrated that, succumbing to the 
same financial and market pressures, doctors routinely prescribed patent medicines and 
provided purveyors with written endorsements for inclusion in advertisements. Loeb argues 
that there was so much deviance from the received position on patent medicines that we must 
acknowledge the co-existence of radically different perceptions within the profession about 
the propriety of consumerism.28 As noted by Sally Frampton, this conclusion is supported by 
a small number of letters from medical practitioners to The Lancet in 1847 and The 
Edinburgh Review in 1872 arguing that the patent system should be used to generate greater 
rewards for invention in medicine.29 Accordingly, the ethical codes put forward by Percival 
and the BMA at either end of the century apparently demonstrating a medical ethical 
opposition to patenting should be treated with caution, and are, at best, indicative of the ideal 
rather than the reality for the majority of medical practitioners.  
Turning away from medicines and directly to the issue of patenting medical 
treatments, the medical journals of the latter half of the century do show arguments were 
raised against this practice. However, on close reading, these also demonstrate division 
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(ed.), The Codification of Medical Morality (Boston: Springer, 1995) pp 191-204.  
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29
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within the profession on the issue. For example, in 1847 an application was lodged for a 
patent for the inhalation of ether in surgical operations. This caused some controversy in the 
medical press and prompted interested practitioners to seek and publish the opinion of 
Queen¶s Counsel. The queries of these interested doctors were couched in the language of 
concern for the welfare of patients, but betray significant anxiety about loss of market share 
should the patent be successful. Letters from both sides, the opinion of counsel and editorial 
comment show that there was consensus that a naturally occurring substance could not be 
patented, but that a process of administrating such a substance requiring a novel device was 
less clear-cut.30 The editors of the Provincial Medical and Surgical Journal referred to the 
application as µDEVXUG¶, but not because a method was part of the claim (as their comment has been 
misinterpreted in subsequent discussion both contemporary and modern) ± WKHµDEVXUGLW\¶UHODWHGWR
the patenting of a naturally occurring substance.  
In the very same pages of The Lancet a further letter appeared from a dentist, J. Chitty 
Clendon, showing clearly that the apparatus used to administer ether ± the process of 
administration ± was an essential component of successfully sedating a patient. This rendered 
fine distinctions between apparatus and medical process meaningless.31 Many medical or 
therapeutic innovations during this period incorporated an array of different components. 
Separating the discovery or adaption of principle or theory from practice would have been 
difficult ± as indeed it would be in the practice of medicine today. In the 1800s, a new 
treatment could include a new or modified device and/or regimes of therapy including 
bloodletting, various placements or movements of the body, and applications of medicines 
either ingested or otherwise applied. Each was considered a vital part of the cure.  
For example, a new treatment for fever might draw on a fashion for cold-water 
dousing that was resurrected during the Napoleonic Wars. Innovations could include the 
repetition and frequency of dousing, the height from which water was dropped, a new device 
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 See various OHWWHUV XQGHU µ,QKDODWLRQ RI $HWKHU LQ VXUJLFDO RpeUDWLRQV¶ (1847) 11 Provincial Medical and 
Surgical Journal DQG µ,QKDODWLRQRI(WKHU LQ6XUJLFDO2SHUDWLRQV¶ (1847) 49 The Lancet 49 (including the 
RSLQLRQRI4XHHQ¶V&RXQVHO  
31Any discussion of whether the internal requirements of the law were incompatible with the practice of 
medicine and thus prevented the development of a patenting culture in the 18th and 19th centuries must consider 
the question of patentability of a process. Dutton demonstrates that there was much confusion over the 
patentability of methods from the mid-18th century. He argues WKDW E\ WKH ¶V WKH SRVLWLRQ RI SDWHQWV IRU
processes was clHDUHUµwith the grant to James Russell in 1834 and to Derosne in 1835¶EXWWKDW it was not until 
1842 with the decision in Crane v Price (1842) 1 WPC 393, that patentees could be fairly certain that methods 
and processes were suitable subjects for a patent: H.I. Dutton The Patent System and Inventive Activity During 
the Industrial Revolution (Manchester University Press, 1984), pp 74-75. More recently, Sean Bottomley has 
demonstrated that the patentability of methods was well-established by the late 18th century, The British Patent 
System and the Industrial Revolution 1700-1852 From Privilege to Property (Cambridge: Cambridge University 
Press, 2014) Ch 5.  
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for dropping the water (or in which to receive the dropped water), and a strict dietary regime, 
bodily exposures and medicines to follow up and effect the cure.32 Similarly the inventions of 
William Adams and James Carmichael Smyth discussed later in this article incorporated new 
ideas, devices to implement those ideas, and follow-up procedures to effect the desired result.   
The case of the ether inhaler, does reveal debate over the professional ethics of 
patenting a new medical treatment, but it is not evidence of a settled position on the subject. 
While many within the profession were happy to condemn the µabsurdity¶ of an attempt to 
restrict the use of a naturally occurring substance, they stopped short of suggesting that 
medical methods should not be patented. Indeed, contemporary and modern representation of 
this patent application as particularly unusual is inaccurate. Although it was not common, by 
this time it was far from unheard of for patent to be granted for a new medical method. This 
article now turns from arguing that there was no widespread ethical opposition to patenting in 
the medical profession of the nineteenth century, to set out new evidence that, in fact, many 
medical practitioners did attempt to use patents and similar legal devices to gain commercial 
benefit from their innovations. 
 
IV. MEDICAL PRACTITIONERS AND THE CULTURE OF REWARD 
a. How they used system  
In contrast to what has been generally represented as a reluctance of the medical profession to 
seek protection for their innovations, it is clear from the available records that medical 
practitioners did seek protection from the emergent intellectual property system in the 
nineteenth century. Existing histories of medicine and intellectual property have underplayed 
the protections that were granted. The widespread practice we have found of medical 
practitioners seeking patent protection for new medicines or new medical devices in the 
period is significant in terms of professional culture. Moreover, our research shows that 
medical methods were also patented. To develop these points further, consideration needs to 
be given to three matters.   
                                                          
32 For examples of such treatments see WKH DFFRXQW RI 5REHUW -DFNVRQ¶V SUDFWLFHV RQ WKH ,VOH RI :LJKW LQ
Proceedings and report of a special medical board appointed by His Royal Highness the Commander in Chief, 
and The Secretary at War to examine the state of the hospital at the military depot in the Isle of Wight, &c. &c. 
&c., (London: L.B. Seeley, 1808); and E. Costello, The adventures of a soldier; or memoirs of Edward Costello 
K.S.F., formerly a non-commissioned officer in the rifle brigade, and late captain in the British Legion (London: 
H. Colburn, 1841). 
10 
 
 First, it should be noted that medicines and medical devices were patented throughout 
the nineteenth century. The existence of such patents has, of course, been noted before,33 but 
the participation of medical practitioners themselves has been overlooked. Across much of 
the nineteenth century, medical practitioners did make regular use of the patent system. For 
example, in the period between 1800 and 1852 slightly more than 20% of English patents 
(29/140) over medicines and medical devices were conferred on medical practitioners.34 It 
must be emphasised that in calculating these figures we have adopted a conservative 
approach to who counts as a medical practitioner during this period, having already noted the 
difficulty of GHPDUFDWLQJWKHFDWHJRU\RIµPHGLFDOSUDFWLWLRQHUV¶SULRUWR Specifically, in 
calculating these figures we have confined ourselves to inventors who identified themselves 
as doctors or surgeons in the application.35 As late as 1899 we still find more than 17% of UK 
patents (33/194) being granted to medical practitioners. Admittedly many of these applicants 
were foreign nationals (with German and US doctors and surgeons doctors being particularly 
prominently represented), but equally it is notable that a high proportion of medical patents in 
general were being filed by foreign applicants at this time.     
A second phenomena that needs to be taken into account when considering the level 
of engagement from medical practitioners with the emergent intellectual property regime in 
the nineteenth century is their use of the parallel, less expensive, system of protection that 
came into operation pursuant to the 1843 Utility Designs Act.36 In the 40 years between the 
utility designs system coming into force and the passage of the Patents, Designs and Trade 
Marks Act 1883 ± which, in effect, brought the utility designs system to an end as a 
distinctive form of protection37 ± at least 30 useful designs were granted over medical devices 
                                                          
33 0RVWUHFHQWO\LQ$0DFNLQWRVKµ$XWKRULW\DQG ownership: the growth and wilting of medicine patenting in 
*HRUJLDQ(QJODQG¶  British Journal for the History of Science  PHGLFLQHV DQG&/ -RQHV µ$
barrier to medical treatment? British medical practitioners, medical appliances and the patent controversy, 1870-
¶British Journal for the History of Science 601 (devices). 
34
 In order to identify the patents in question we took as our starting point the Abridgement of Specifications 
relating to Medicine, Surgery, and Dentistry AD 1620-1866 (London: Printed by Order of the Commissioner of 
Patents, 2nd edn, 1872). We then excluded applications for improvements in artificial teeth, veterinary 
medicine, pill boxes, coffins and other funereal items, and general improvements in manufacture that were 
claimed to have an application to medicine e.g. improvements in the manufacture of steel tools.       
35
 As such, we excluded applications by apothecaries, medical botanists, medical chemists and other inventors 
who would at the time have been understood to have had a legitimate role in the medical marketplace.    
36  (1843) 6 & 7 Vict. c.65. On the rise and fall of the useful design system see B. Sherman and L. Bently, The 
Making of Modern Intellectual Property Law (Cambridge: Cambridge University Press, 1999) Ch 4. 
37
 See J.E. Crawford Munroe, The Patents, Designs and Trade Marks Act 1883 (London: Stevens & Sons 1884), 
p  QRWLQJ WKDW WKH  $FW µKDV DPRQJVW RWKHU WKLQJV DEROLVKHG WKH GLVWLQFWLRQ EHWZHHQ XVHIXO DQG
RUQDPHQWDOGHVLJQV¶ and citing the Memorandum on the Bill WRFRQFOXGHWKDWµVXFKXVHIXOGHVLJQVDVembrace 
mechanical action would be treated as subject-PDWWHU IRUDSDWHQW¶6HHDOVR/%HQWO\DQG%6KHUPDQ µ7KH
8QLWHG.LQJGRP¶V)RUJRWWHQ8WLOLW\0RGHO WKH8WLOLW\'HVLJQV$FW¶>@,34SRLQWLQJRXW
that after 1883 courts refused to UHFRJQLVHWKDWDGHVLJQ¶VQRYHOW\FRXOGVXEVLVWLQDQ\WKLQJRWKHUWKDQVKDSH    
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to those identifying as doctors or surgeons, as listed in Appendix A. Moreover, at least some 
attention must be given to the use by medical practitioners of the ornamental designs system. 
Although applications for such protection do not seem to have been common and, in any 
event, do not give rise to the same ethical issues (bearing in mind that ornamental designs, 
much like the modern registered design system, extended only to protect the surface features 
of objects and not the underlying operating principles) they help establish that a significant 
number of practitioners were not opposed to using the available legal technologies to secure 
market exclusivity for their creations.38 
Importantly, the use of these early forms of intellectual property protection by 
medical practitioners is consistent with what we know about the operation of the medical 
marketplace generally during this period. As Sally Frampton has argued, by this time a 
professional culture had evolved where profit-making and proprietary gestures in medicine 
had to be negotiated with care but, importantly, they were made.39  
If medical practitioners were not opposed to protecting some forms of innovation then 
a third matter that demands attention is how the patent system dealt with claims for methods 
of medical treatment in the nineteenth century. As we have already noted, existing histories 
of the MME are premised on the view that medical practitioners were opposed to patenting 
medical innovations and C&W gave partial effect to this opposition by excluding one type of 
medical breakthrough from the scope of protection. However, there has been almost no 
engagement with the state of the law prior to C&W. This is important because an analysis of 
the position prior to C&W suggests that there were numerous examples of applications for 
patents over methods of medical treatment over the course of the nineteenth century. 
Specifically, we have identified more than 35 examples of claims to methods of medical 
treatment, as set out in Appendix B.40 In compiling this list we have excluded patents 
detailing methods for the removal of teeth and attachment of artificial teeth, of which there 
were a significant number.41 We have also excluded patents where there is some degree of 
ambiguity as to whether the intention was to claim a method or a novel product. Included in 
                                                          
38
 See, e.g., Registered design number: 250232 (BT 43/68/250232) Proprietor: Edmund Adolphus Kirby, Doctor 
of Medicine (portable case) 1871; Registered design number: 329010 (BT 43/62/329010) Proprietor: Francis 
Thomas Bond, Doctor of Medicine (enclosure for a thermometer) 1878; Registered design number: 346951 (BT 
43/72/346951) Proprietor: Robert Foulis, Doctor of Medicine (pocket jemmy) 1880. 
39
 S. Frampton, µ+RQRXU DQG VXEVLVWHQFH LQYHQWLRQ FUHGLW DQG VXUJHU\ LQ WKH QLQHWHHQWK FHQWXU\¶  
British Journal for the History of Science 561. 
40
  In a small number of cases these applications did not progress beyond provisional protection, but in most 
cases full protection was sought and granted.  
41
 6HH IRUH[DPSOHQR -RKQ+DLQHV:KLWH µ$Q LPSURYHPHQW LQ WKHPHWKRGRIDSSO\LQJDUWLILcial 
WHHWK¶ 
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our list are, admittedly, examples of patents that claim a method of treatment using a new 
instrument or medicine which is itself claimed in the patent. In such cases one might argue 
that the method claim is purely secondary and that it is the device or medicine that is central. 
However, such applications at the very least demonstrate that late into the century there was 
no legal impediment to patenting methods of medical treatment.42 In any event, moreover, 
there were cases in which the method was central to the invention claimed. Consider, for 
example, %RQQHW¶V DSSOLFDWLRQ IRU µCertain improvements in the mode of preparing and 
applying chemical fumigations to the treatment of human diseases, and in apparatus 
connected therewith¶. Although, as the title makes clear, the patent did describe a particular 
apparatus, WKHVSHFLILFDWLRQDOVRPDNHVFOHDUµWKDWVHYHUDOYDULDWLRQVLQWKHFRQVWUXFWLRQRIWKH
DSSDUDWXVFDQEHHIIHFWHGZLWKRXWGHYLDWLQJ IURP WKHSULQFLSOHRIP\ LQYHQWLRQ¶ Claims to 
VLPLODUHIIHFWDUHWREHIRXQGLQ0DFKHOO¶VVSHFLILFDWLRQIRUµAn improved method of applying 
for medical purposes, the agency of atmospheric air«¶; in Prichard¶V, DSSOLFDWLRQ IRU D µA 
new method of relieving pain in the human body¶; and in -RKQVRQ¶VFODLPIRUDQ µImproved 
means for destroying disease germs.¶ 
From WKHDERYHLWLVFOHDUWKDWWKHPHGLFDOSURIHVVLRQ¶VUHODWLRQVKLSZLWK patents and 
the other types of intellectual property protection was neither straightforward nor universally 
hostile. It is not even possible to state that innovative methods of medical treatment were 
incapable of being patented and it is clear that despite any aspirational statement to the 
contrary, a significant number of financially harassed practitioners held ethical positions fluid 
enough to support an association with patents (or utility designs) over new medical devices. 
Here it is also worth emphasising that the statements of ethics never drew a distinction 
between methods of medical treatment and other forms of invention. This is hardly surprising 
given that it is difficult, if not impossible, to see how any such distinction could be drawn 
from a medical ethics perspective.43 It is therefore DSSDUHQW WKDW %XFNPDVWHU¶V DVVHUWLRQ in 
1903 of an ethical standard in medicine opposed to patenting of medical methods was not 
supported by longstanding practice and that there continued to be a significant degree of 
ambiguity in the relationship between the medical profession and the intellectual property 
                                                          
42
 7KLVLVDOVRFRQVLVWHQWZLWKWKHSRVLWLRQDGRSWHGLQ7HUUHOOWKH8.¶VOHDGLQJWUHDWLVHRQSDWHQWODZ7KH 3rd 
edition published in 1895 contains nothing to suggest that methods of medical treatment were not patentable 
subject matter: W.P. Reynolds, The Law and Practice relating to Letters Patent for Inventions (London: Sweet 
& Maxwell, 3rd edn, 1895). Even by the time of the 6th edition, published in 1921, C&W was explained on the 
basis that the claim in that case had been poorly drafted and not on the basis that it had established a new 
exclusion from patentability: C. Terrell and A. Jaffé. The Law and Practice relating to Letters Patent for 
Inventions (London: Sweet & Maxwell, 6th edn, 1921), in particular, at p 31.  
43
 See also E. Ventose, Medical Patent Law ± The Challenges of Medical Treatment (Cheltenham: Edward 
Elgar, 2011).  
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system. However, as the century progressed attitudes against patents generally do appear to 
have hardened and across the period the medical profession never established the type of 
widespread culture of patenting that we find in other fields of technical and scientific 
endeavour. Moreover, it is notable that members of the (narrowly defined) medical profession 
were generally not responsible for patenting methods of medical treatment. Of the previously 
unnoticed inventions set out in Appendix B we have only been able to identify three 
examples of methods patents that were claimed by members of the medical profession and in 
one of these cases the inventor was resident in Paris. The reason for the underutilisation of 
the intellectual property system by the medical profession, in particular, as regards methods 
of treatment, is explored in the next section. 
 
b. :K\WKHV\VWHPZDVµXQGHUXWLOLVHG¶ 
One of the most obvious disincentives to greater use of the patent system by medical 
practitioners during this period would have been the cost of obtaining a patent. The economic 
circumstances of most medical practitioners, as outlined above, were strained. The cost of 
obtaining a patent was widely regarded as prohibitive well into the mid-nineteenth century, 
IDPRXVO\ UHVXOWLQJ LQ &KDUOHV 'LFNHQV¶ SDURG\ $ 3RRU 0DQ¶V 7DOH RI D 3DWHQW44 More 
specifically, evidence given before the 1829 Select Committee suggests that the ordinary cost 
of obtaining a patent for England alone was something in the order of £120, whilst to secure 
protection for the entirety of the UK cost somewhere between £345 and £500.45 Anne 
'LJE\¶V UHVHDUFKRQ WKH LQFRPHRIPHGLFDOSUDFWLWLRQHUVDFURVV WKHQLQHWHHQWKFHQWXU\SXWV
these figures in context ± the most eminent Physician in London had an annual income of 
£12,000 in 1829, while a young physician in London might hope to earn only £200. 
Provincial practice was significantly less rewarding. By 1877, the median gross income for 
general practitioners across England was about £600.46 Clearly, for many medical innovators 
a patent application would have been beyond their reach.  However, this impediment cannot 
account entirely for the failure of the early medical profession to develop a culture of seeking 
legal protection for innovation.   
                                                          
44
 This essay was originally published in (1850) 2 Household Words 73. This essay is readily available in a 
variety of formats online, but a scanned version of the original is available at: www.djo.org.uk/household-
words/volume-ii/page-73.html.    
45
 Report from the Select Committee on the Law Relative to Patents for Inventions (332) (12 June 1829), pp 12, 
17. 
46
 Digby, Making a Medical Living, pp 156, 190-1. 
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Of equal importance, in our view, is the manner in which medicine was practised 
during the period, which was not compatible with the internal requirements of the law. 
Novelty has always been an essential requirement for a valid patent. While this concept is not 
straightforward and has changed over time, it was already well-established that if SULRUµXVH
of an invention had been public, any subsequent patent for that invention would be 
YRLGDEOH¶47 Importantly, moreover, tKHWKUHVKROGIRUµSXEOLFXVH¶FRXOGEHH[WUHPHO\ORZ,n 
the 1841 decision Carpenter v. Smith,48 it was held that the µSXEOLFGLVSOD\¶RID lock on a 
gate for sixteen years was enough to invalidate a later patent application for a lock with a 
similar mechanism, even though the only time when the mechanism was open for inspection 
was on the one occasion when it had been taken for repair. The strictness of the novelty 
requirement was significant because of the nature of nineteenth century medical practice.  
In Britain, the nineteenth century was an important point of transition in medicine, 
associated strongly with the rise of the hospital. Despite the persistence of older models of 
bedside medicine, particularly for the upper classes, increasingly doctors worked in and did 
VRPHRIWKHLUWUDLQLQJDWKRVSLWDOV6XVDQ/DZUHQFHH[SODLQVWKDWµKRVSLWDOPHGLFLQHEHFDPH
in a fundamental sense...public PHGLFLQH¶ 1RW RQO\ ZHUH SDWLHQWV REVHUYHG E\ SXSLOV
practitioners, visitors and other patients, but the treatment of patients was also observed by a 
ZLGH YDULHW\ RI VSHFWDWRUV $V µZDUG-ZDONLQJ¶ EHFDPH DQ HQWUHQFKHG SDUW RI PHGLFDO
HGXFDWLRQ µSXSLOV DQd other practitioners regularly saw staff men deploying their authority 
RYHUNQRZOHGJHDQGLQWHUDFWLQJZLWKHDFKRWKHU¶49  
The very nature of medical practice and the establishing of expertise in this early 
period required a significant amount of public display. Operations were often performed in 
theatres with rows of ranked seating. They were attended by many observers: including 
physicians, other surgeons, and students.50 The impact of a poorly executed public operation 
RQ D VXUJHRQ¶V UHSXWDWLRQ FRXOG EH Gisastrous. As Michael Brown describes, one such 
incident demonstrates not only the public nature of such work, but the importance of 
                                                          
47 Bottomley, British Patent System, p 166. Bottomley discusses the novelty requirement, its relation to first 
authorship and its interpretation by the courts in detail at pp 162-168. For a contemporary analysis see R. 
Godson, A Practice Treatise on the Law of Patents for Inventions and of Copyright, (London: William Benning, 
2nd edn, 1844) pp. 41-49. 
48 (1841) HPC 754. See also Jones v Pearce 1831 [1844] :HEVWHU¶V3DWHQW&DVHVSXEOLFXVHRIFDUULDJH
wheels). 
49
 S. Lawrence, Charitable Knowledge, Hospital Pupils and Practitioners in Eighteenth Century London 
(Cambridge: Cambridge University Press, 1996) p 23.  
50
 L. Brock, µAn eighteenth-century amputation scene in the men's operating theatre of old St Thomas's 
Hospital¶ (1977) 59 Annals of the Royal College of Surgeons of England 415. 
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wiWQHVVHV IRU D VXUJHRQ¶V FDUHHU51 This was the case of Bransby Cooper whose botched 
lithotomy operation on the unfortunate Stephen Pollard resulted in widely read gruesome 
reports and articles, and a libel trial so popular with the public that there was not room for all 
those who wished to attend.52 
Relevantly, the operation had been performed in Guy¶s Hospital (one of /RQGRQ¶V
most prominent at the time) and, as was routine, was attended by a large number of people. 
6HYHUDORIWKRVHDWWHQGHHVODWHUVHUYHGDVZLWQHVVHVDWWKHWULDO%URZQ¶VLQ-depth treatment of 
this incident demonstrates the many layers of public fora: operating theatre, print media, and 
courtroom in which medicine was practised, discussed and evaluated during the early 
nineteenth century. These fora persist today, but in the nineteenth century carried even more 
significance in the absence of widely agreed and accepted, objective, clinical indicators of 
success.53 Of course, the public performance of a new method of operating, or exceptional 
skill in the operating theatre, could also be the making of a career. William Adams, to whom 
we will return in the following section, relied heavily on the observations of others to support 
his claims to inventing a procedure (for which he wanted recognition and a reward) in the 
surgical treatment of Egyptian Ophthalmia.54  
 The observation of practice in this period also extended to detailed publications, both 
ZLWKLQ WKH HOLWH YLUWXDO SXEOLF VSDFH RI WKH VFLHQWLILF µUHSXEOLF RI OHWWHUV¶ DQG LQ SDPSKOHWV
designed to be read by (or read to) the masses, especially those at a physical distance from the 
practice of the therapy.55 Edward Jenner, discoverer of vaccination, used this latter public 
space to great effect after trying, and failing, to find a willing patient for a public 
demonstration of vaccination in London.56 His self-published work, An inquiry into the 
causes and effects of the variolæ vaccinæ, a disease discovered in some of the western 
                                                          
51
 M. Brown, µ%DWV 5DWV DQG %DUULVWHUV¶ The Lancet, Libel and the Radical Stylistics of early Nineteenth-
FHQWXU\(QJOLVK0HGLFLQH¶ (2014) 39 Social History 182. 
52
 (1828) 9 The Lancet 959. 
53
 C. Lawrence, Medicine and the Making of Modern Britain, (London: Routledge, 1994) p. 29. 
54
 Official papers relating to operations performed by order of the directors of the Royal Hospital for Seamen, 
at Greenwich, on several of the pensioners belonging thereto, for the purpose of ascertaining the general 
efficacy of the new modes of treatment practised by Sir William Adams, for the cure of the various species of 
cataract, and the Egyptian ophthalmia, published by order of the Directors (London: Manufactory for 
Employment of the Deaf and Dumb, 1814). 
55
 On the scientific republic of letters see J. Gascoigne, Science in the Service of Empire, Joseph Banks, the 
British State and the uses of Science in the Age of Revolutions (Cambridge: Cambridge University Press, 1998). 
56
 J. Baron, Life of Edward Jenner (London: Henry Colburn, 1827) p 150. 
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counties of England, ... and known by the name of the cow pox,57  has been described as a 
µdo-it-yourself guide to vaccination¶GLVSOD\HGµfor everybody to see¶.58 
Similarly, some of the most productive engines of medical and surgical innovation 
during the early 1800s were the British Army and Navy engaged in fighting the Napoleonic 
Wars. These vast enterprises employed large numbers of energetic medical practitioners 
many of whom, such as the famous surgeon George Guthrie, actively sought to improve 
surgical technique and treatments.59 Many others were forced to innovate in the face of 
necessity or desperation.60 Military medical leaders perceived the importance of the speedy 
capture and dissemination of new techniques. These were transferred to young surgeons 
through observation and training in battlefield hospitals, and through sophisticated systems of 
reporting and correspondence.61 Innovations in this context became firmly embedded within 
military command structures, and rapidly taken up by other practitioners. There was little 
private physical or intellectual space for invention at war and innovations from military and 
naval medicine spread quickly and widely.62  
 From the discussion above, we can see that in this period the conditions for the secret 
creation, trial and development of new medical methods were rare. Unlike the cloistered 
environment of the birth chamber famously exploited by the Chamberlen family to profit 
from their invention of forceps,63 nineteenth century medicine was predominantly public and 
observed. As described above, there is a general perception that medicine during this period 
embraced a set of enlightenment values, despising secrecy and rewarding public beneficence 
                                                          
57
 (London: printed for the author by Sampson Low, 1798). 
58
 G. Williams, µFrom Jenner to Wakefield: The long shadow of the anti-vaccination movement¶, Gresham 
College Lecture, 28 September 2011, available at <http://www.gresham.ac.uk/lectures-and-events/from-jenner-
to-wakefield-the-long-shadow-of-the-anti-vaccination-movement>. 
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 See generally, M. Crumplin, *XWKULH¶V:DU$6XUJHRQRIWKH3HQLQVXOD	:DWHUORR (Barnsley: Pen & Sword, 
2010). For contemporary views on the importance and propriety of experiment and innovation within military 
hospitals see Proceedings and report of a special medical board appointed by His Royal Highness the 
Commander in Chief, and The Secretary at War to examine the state of the hospital at the military depot in the 
Isle of Wight, &c. &c. &c. (London: Seely 1808). 
60
 C. Kelly, War and the Militarization of British Army Medicine (London: Pickering & Chatto, 2011), Chs 3-5. 
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RI0HGLFLQH´: the 18th Century British Origins of a Critical Approach (Edinburgh: Royal College of Physicians 
of Edinburgh, 2000); M. Harrison, Disease and the Modern World, 1500 to the Present Day (Cambridge: Polity, 
2004) p 57; D.P. Geggus, Slavery, War and Revolution: The British Occupation of Saint Domingue, 1793-1798 
(Oxford: Clarendon, 1982) pp 347-72; E. Charters, µ³The Intention is CertaiQO\1REOH´: The Western Squadron, 
Medical Trials and the Sick and Hurt BRDUGGXULQJWKH6HYHQ<HDUV:DU¶LQ'+D\FRFNDQG6 Archer (eds), 
Health and Medicine at Sea, 1700-1900 (Woodbridge: Boydell, 2009). 
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 Kelly, ibid, Chs 3 and 5. 
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 30DWKLDVµ6ZRUGs into Ploughshares: the Armed Forces, Medicine and Public Health in the Late Eighteenth 
&HQWXU\¶LQ-:LQWHUHG), War and Economic Development: Essays in Memory of David Joslin (Cambridge: 
Cambridge University Press, 1975) p 80. 
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 P. Dunn, µ7KH &KDPEHUOHQ )DPLO\ ± DQG REVWHWULF IRUFHSV¶ (1999) 81 Archives of Disease in 
Childhood, Fetal and Neonatal Edition F232. 
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in the name of science. While this may have been true for some practitioners, it is also true to 
observe that for any practitioner desiring a successful career it would have been impossible to 
thrive in most areas of practice without carrying out his trade publicly and under observation. 
This would have created a significant obstacle to the development of a patenting culture for 
new inventions. The problem would have been least acute for new medicines which could be 
both developed in secret and administered without divulging their formulation. Devices could 
be developed in secret, but any serious attempt to bring them into use prior to seeking 
protection would have rendered them unpatentable. Medical and surgical methods faced the 
most serious obstacles as generally they could only be developed under public scrutiny and 
many of the most useful would have been in wide circulation and practised by others soon 
after they were developed. It is not (and was not) feasible to apply for a patent when everyone 
knows what you did, how you did it, and they are already copying you.  
   
 
V. MEDICAL PRACTITIONERS BEFORE PARLIAMENT  
We have shown that medical innovators in the nineteenth century did not sit back and accept 
their contribution to human welfare as its own reward. Many devices and some medical 
methods were patented, and not only by the lower orders of the profession. Edward Jenner 
himself had contemplated patenting one of his earlier medical innovations on the advice of 
the eminent surgeon John Hunter.64 However, as set out above, the public nature of medical 
experiment and innovation in the early nineteenth century meant that new medical treatments 
were usually well-known. Patent protection was therefore often not available, even in the 
cases where the inventor had the financial means to pursue it. Further evidence that medical 
practitioners were comfortable making a profit from saving lives is provided by the way in 
which some leading medical practitioners availed themselves of an alternate means of 
securing recognition for their inventions by lodging a petition for a Parliamentary reward. 
As we have described in detail elsewhere, by the early nineteenth century the British 
State had developed an elaborate system of rewards that ran in parallel with the patent 
system. This system had myriad components, including cash rewards and patent extensions 
administered by Parliament, financial rewards and prizes administered by other public and 
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 0DFNLQWRVKµ$XWKRULW\DQG2ZQHUVKLS¶DW 
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quasi-public bodies, and less commonly utilised arrangements such as pensions for inventors 
and tax incentives for innovation.65  
Innovative medical practitioners were at times enthusiastic participants in this system 
of rewards. Indeed, one of the earliest Parliamentary rewards was the payment of £5,000 to 
Johanna Stephens in 1739 in return for her divulging her secret remedy µIRU UHPRYLQJ WKH
FDXVH RI WKH VWRQH¶.66 However, the applications for rewards that are of most interest for 
present purposes are the appeals made to Parliament by three prominent medical practitioners 
in the early 1800s. These appeals related to discoveries already in the public domain and in 
each case resulted in the payment of a significant sum of public money. The most widely 
known recipient of such an award is Edward Jenner, inventor of smallpox vaccination, who 
received £10,000 in 1802 and a further £20,000 in 1807. +RZHYHU -HQQHU¶V ZDV QRW DQ
isolated case. At around the same -HQQHU¶V LQLWLDO SHWLWLRQ ZDV SUHVHQWHG WR 3DUOLDPHQW Dr 
James Carmichael Smyth petitioned for a reward and was granted £5,258 in respect of his 
GLVFRYHU\ RI µQLWURXV IXPLJDWLRQ¶ 6HYHUDO \HDUV ODWHU Parliament granted £4,000 to Sir 
William Adams in recognition of his innovations in the treatment of Egyptian Ophthalmia.67  
The debates over these three applications, along with the reports of the relevant Select 
&RPPLWWHHV SURYLGH LQVLJKW LQWR FRQWHPSRUDU\ SHUFHSWLRQVRIPHGLFLQH¶V UHODWLRQVKLSZLWK
FUHGLW DQG SURILW YLHZV RQ WKH SDWHQW V\VWHP DQG WKH 6WDWH¶V UROH LQ HQGRUsing and 
incentivising new research. Claims for a reward in the medical field were particularly fertile 
ground for this discussion because advances often did not fit neatly with the emergent 
categories and requirements of intellectual property and because of the unique public good 
aspect of medical advances. The debates in Parliament make it clear that the medical 
protagonists had worked hard to procure powerful political patrons who felt very passionately 
about these issues. Jenner is well known to have had influential patrons, but it is interesting to 
note that Jenner EHOLHYHG6P\WK¶VDSSOLFDWLRQZDVJLYHQDQHDVLHUtime in Parliament because 
of 6P\WK¶V better connections.68 Adams faced so much violent political opposition that his 
reputation would have been destroyed if not for his powerful advocate, Lord Palmerston. 
Medical practitioners and interested patrons supplemented their lobbying of Parliamentarians 
ZLWKDSSHDOVWRWKHSXEOLFWKURXJKZULWWHQZRUNV7KHVHWDFWLFVRIµH[FLWLQJLQWHUHVW¶LQWKHLU
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cause bear great similarity to those of the Benthamites identified by Samuel Finer.69 It is not 
surprising then, that these three petitions yield especially hard fought and engaged 
Parliamentary debate. 
6P\WK¶VLQYHQWLRQ was a method of fumigating rooms (or decks below ship) to rid the 
area of contagion (disease). +LVPHWKRGZDVWRPL[µSXUHQLWUHLQSRZGHUDQGFRQFHQWUDWHG
YLWULROLFDFLG¶LQDSLpkin which was then carried through an infected area.70 Fumigation had 
ORQJEHHQXVHGLQWKHILJKWDJDLQVWFRQWDJLRQKRZHYHU6P\WK¶VFODLPWRLQQRYDWLRQOD\LQWKH
ability of the patients to remain in the room and breathe during the administration of his 
fumigation, a circumstance not possible in the common fumigations at the time which used 
muriatic or sulphuric acids. In 1795, under the orders of the Lords Commissioners of the 
Admiralty, Smyth KDGRUJDQLVHGD WULDORI WKHQLWURXV IXPLJDWLRQPHWKRGRQ+LV0DMHVW\¶V
ship The Union at Sheerness, where there had been an outbreak of fever. According to Smyth, 
his experiments were a success and, reflecting the rapid dissemination of effective therapies 
in the armed forces during this period, his methods were then used widely in the Navy, by 
military surgeons and in prisons.71 
In 6P\WK¶V DSSOLFDWLRQ he first and foremost acknowledges the dilemma facing a 
public-spirited medical inventor, and highlights that he (nobly) chose to sacrifice an 
opportunity of private wealth to benefit the public: 
 ... the Petitioner, by devoting so much of his Time to an Object of public Utility, has 
sacrificed private to public Advantage...the Petitioner, for all his Labours, has as yet 
received no Recompense or Reward...And therefore praying the House to...grant him 
such Reward for his Services to the Public72 
All claims for Parliamentary rewards made reference to public benefit, but in the case of 
medical discoveries implicit reference was also made to the possibility of keeping the 
LQYHQWLRQVHFUHW -HQQHU¶Vsupporters stated that his discovery had µbeen given to the world 
with liberality¶EXWQRWHGWKDWµIf he had pursued a contrary conduct, he would have realised a 
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SULQFHO\ IRUWXQH¶73 µ&RQWUDU\ FRQGXFW¶ FRXOG RQO\ KDYH PHDQW NHHSLQJ WKH GHWDLOV RI WKH
inoculation process secret, it being accepted by all sides that Jenner µFRXOGH[SHFWQRUHZDUG
IURPWKHPHWKRGRISDWHQWVZKLFKZHUHQRWDSSOLFDEOHLQWKHSUHVHQWFDVH¶74  
Across the early nineteenth century we see Parliament concerned to ensure that 
medical advances (in particular) were placed in the public domain. This can be seen, for 
example, in debates during the passage of the Patents Act 1835, which conferred the power to 
award patent term extensions on the Judicial Committee of the Privy Council. Lord 
Brougham, who introduced the Bill in the Lords, justified the new procedure on the grounds 
that it was better to hold out to inventors of new medicines the prospect of an extended 
monopoly than to run the risk that they would keep their inventions secret.75 3DUOLDPHQW¶V
push for disclosure was not confined to medical inventions.76 Insofar as innovations in the 
medical field attracted additional demands for public accessibility this can be readily 
explained by the strong public interest in ensuring access to lifesaving treatments. There 
does, however, also seem to have been an acceptance in Parliament that members of the 
respectable medical profession would not have been able to keep their inventions secret 
(either until patented or on an ongoing basis) without causing significant harm to their 
professional standing: reputable medicine was medicine that was practised in public.   
In working out whether to give rewards to these three medical practitioners 
Parliament also considered its role in endorsing and promoting inventions for the public 
good. These were objectives that many Parliamentarians came to embrace. It was put during 
GHEDWHV RQ WKH TXDQWXP RI 'U -HQQHU¶V LQLWLDO UHZDUG WKDW WKH +RXVH RI &RPPRQV ZHUH
JXDUGLDQVµRIWKHLQWHUHVWVRIWKH3XEOLF¶ ZLWKUHVSRQVLELOLW\IRUSUHVHUYLQJSXEOLFKHDOWK¶77 In 
/RUG :LOEHUIRUFH¶V YLHZ Parliamentary remuneration would not merely recognise his 
individual contribution, it would also VHUYH DV DQ µDXWKHQWLFDWLRQ RI WKH GLVFRYHU\ DQG «
force it into speedy and universal practice¶78 Lord Wilberforce made a similar point in the 
course of debates over whether to grant Smyth a reward, noting that the grant would µstamp 
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the utility of the discovery in the mind of the Country, bring it into general use, and thus call 
forth all its advantages¶.79  
 7KH6WDWH¶V UROH LQHQGRUVLQJ LQQRYDWLRQZDVDOVRDW WKHIRUHIURQWRIGHEDWHVDURXQG
$GDPV¶SHWLWLRQIRUDUHZDUG,QWKLVcase, one sees Parliament having to engage with a hard-
fought intra-professional dispute as to who should be given credit for the invention of the 
new surgical procedure (and attendant convalescent regime) for the treatment of Egyptian 
Ophthalmia. It was put strongly to Parliament both that Adams was attempting to claim credit 
for the innovations of his mentor John Cunningham Saunders, and that another rival surgeon, 
Dr JohnVetch had invented the procedure. 
One reason it was difficult to establish who had invented the procedure was that it had 
not been unknown in Antiquity. Vetch published a pamphlet to bolster his claim, but rather 
than insisting that the procedure was entirely novel he claimed that he had in fact revived a 
practice of the Ancients. The revival or rediscovery of ancient knowledge was very much in 
vogue GXULQJWKLVSHULRGDQGµthe Ancients¶ had important cachet in the medical marketplace. 
To modern eyes rediscovering a practice is not µLQYHQWLRQ¶, but it must be remembered that 
the UK still granted patents over technologies imported from overseas at this time. For Vetch 
his entitlement for credit could be summarized as follows:  
I nevertheless consider that he who revives a useful practice, after it has fallen into 
general disuse and oblivion, is entitled to as much merit as if he had made the 
discovery in point of time as well as in point of fact; and every liberal person must 
regret that the knowledge of antiquity should ever be used to obscure the reputation of 
a successful innovator.80  
8OWLPDWHO\3DUOLDPHQWEDFNHG$GDPV¶FODLP for a reward, whilst nevertheless commending 
the knowledge and skill of Dr Vetch. )RU3DUOLDPHQW LWZDV HQRXJK WKDW$GDPVKDG µEHHQ
greatly instrumental in promulgating this knowledge, and in rendering it generally 
DYDLODEOH¶81 Parliament was therefore able to sidestep the difficult question of exactly how to 
apportion credit between Vetch and Adams, both of whom had being trying to revive 
abandoned practices. Parliament noted that it might be left to profession and the public to 
determine who deserved the greater credit.82 ,QSUDFWLFHKRZHYHU3DUOLDPHQW¶VGHWHUPLQDWLRQ
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that both men were worthy, but that Adam had a stronger case given his labour in bringing 
the treatment into general use settled the matter. Parliament¶VUROHDWWKLVWLPHZDVVWLOOWKDWRI
WKHQDWLRQ¶VµJUDQGtribunal¶ and explicit or implicit Parliamentary endorsement of a medical 
SUDFWLWLRQHU¶VH[SHUWLVHhad the capacity to be influential, particularly since there was a good 
prospect that it would be picked up in the press.83  
 Medical practitioners began to engage seriously with Parliament on a regular basis in 
the late eighteenth and early nineteenth centuries, in particular, through the numerous 
inquiries that Parliament held into matters of military and public health.84 The reasons for this 
engagement were many and varied. There is no reason to doubt that practitioners were 
engaging with Parliamentary enquiries out of concern to improve the health of the nation. We 
can nevertheless accept that regular, in-depth engagement with Parliament also provided 
doctors with an opportunity to further their collective goal of professionalisation.85 In much 
the same vein, we can say that the Parliamentary inquiry provided individual practitioners 
with an opportunity to promote their expertise, to have this expertise acknowledged and to 
have this reported by the press without doubting that they were acting in good faith. Requests 
for Parliamentary rewards provide the most overt examples of practitioners seeking 
Parliamentary endorsement of medical expertise and the efficacy of particular treatments, but 
they can also be seen as part of D ELJJHU SLFWXUH ZKHUH PHUH GLVFXVVLRQ RI D SK\VLFLDQ¶V
expertise in Parliament could be expected to enhance his practice.86    
The engagement of medical practitioners with Parliament generally in the period can 
therefore be viewed as one of a number of strategies used by medical innovators to secure 
recognition and to use the resulting reputational advantage to leverage financial success. 
Sally Frampton has written about the attempts of surgical innovators to negotiate credit and 
about the disputes that sometimes arose regarding who invented what and when.87 More 
recently, Alan Mackintosh has demonstrated that excise stamps that had to be applied to 
patent medicines between 1783 and 1812 gave an impression of official endorsement. The 
presence of these stamps also created a strong disincentive to copying because forging a 
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stamp was a capital offence.88 Even in cases where a patent was also obtained over a 
medicine, its value often lay more in the marketing advantage the patent conferred on the 
proprietor, than in the period of monopoly protection per se.89 Against this background one 
can appreciate the desire of surgeons to ensure that instruments they invented carried their 
name.90 It also puts into context the fact that it was actors in the medical marketplace who 
were responsible in the late eighteenth century for the early development of trade mark rights 
at common law,91 and explains why doctors and druggists featured prominently in the 
nineteenth century among the groups that sought to use the emergent tort of passing off to 
protect their reputations.92    
  The ability of medical professionals to rely on reputational capital as a means of 
securing market advantage was enhanced by the way in which the public related to medical 
expertise. It was noted above that for much of the period there was an absence of objective, 
clinical indicators of success.93 The successful transmission of expertise and the replicability 
of results was much harder to assess, making reputation a surer guarantee that patients would 
seek out the originator. Precisely this point was aired in Parliament during discussions around 
-HQQHU¶VSHWLWLRQMr Bankes MP opposed granting Jenner a significant reward on the 
grounds that medical inventions generally produced a reward for the inventor without the 
need for any State interference. This was because patients, especially those with money, who 
desired WKHWUHDWPHQWZRXOGSUHIHUJRµWRWKHIRXQWDLQ-KHDG¶, even after the method was well-
known and practised by others.94  
 
VI. CONCLUSION  
The picture that emerges from our study is not one of strong principled opposition to 
intellectual property rights (as we would now think of them) from medical practitioners in the 
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nineteenth century. In contrast to much of what has been written on this topic, it was accepted 
that profit could legitimately motivate upstanding members of the profession. It was accepted 
that a medical method could be patented. Moreover, medical practitioners saw themselves as 
EHLQJHQWLWOHGWRPDNHDµFODLP¶ over their inventions. This led them to explore a variety of 
different approaches as they sought to take advantage of a still fluid legal landscape. Our 
study presents significant new evidence of these interactions between the medical profession 
and both the patent and utility design systems.  
However, the underutilisation of these protections (which has given rise to 
misconceptions about medical ethics) must also be explained. We have argued that this 
explanation lies in the law. The public nature of medical practice was such that innovations 
were often ineligible for protection. By the early nineteenth century medicine had become a 
public enterprise. Innovation often occurred in public or was immediately exposed to public 
scrutiny. The internal requirements of patent law could thus not be met and keeping the 
invention secret on an ongoing basis was an even less viable option.  
We have argued further, that medical innovators were therefore forced to look for 
alternatives, in some cases turning to the system of Parliamentary rewards. These rewards 
prompted the State to engage closely with the nature of medical innovation and its 
compatibility with the developing principles governing the patent system. These applications 
for rewards and the interaction of doctors with Parliament more generally also help illustrate 
the strong desire of medical practitioners to secure public recognition for their creations. 
Public recognition was not seen exclusively as an end in itself; it was also vital to securing 
economic advantage. For most practitioners in most circumstances focusing on reputational 
enhancement was a more promising option than seeking protection through the patent system.  
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Appendix A:  
Year Proprietor Useful Registered 
Design Number 
(National Archives 
collection reference) 
Description 
1847 George Dixon Hedley, MD  1029 (BT 
45/6/1029) 
Improved inhaler. 
1847 Henry Ward, Surgeon 1038 (BT 
45/6/1038) 
Ether inhaler. 
1847 William John Bowden, 
Surgeon 
1055 (BT 
45/6/1055) 
Improved pneumatic inhaler. 
1847 Keith Imray, Doctor of 
Medicine 
1143 (BT 
45/6/1143) 
Pessary for the relief of prolapsus 
uteri or prolapsus ani. 
1847 John William Phelps, 
Doctor of Medicine 
1144 (BT 
45/6/1114) 
Improved spiral abdominal 
supporter for prolapsus uteri. 
1848 Marius Pierre Philip 
Bourjeaurd, Surgeon 
1362 (BT 
45/7/1362) 
Elastic surgical bandage. 
1848 Marius Pierre Philip 
Bourjeaurd, Surgeon 
1639 (BT 
45/9/1625) 
Elastic suspensor. 
1849 Marie Maurice Gariel, MD  1787 (BT 
45/9/1787) 
7KHµ$TXHGXFWRU¶IRUVXUJLFDO
purposes. 
1849 John Goodman, Member of 
the Royal College of 
Surgeons 
1863 (BT 
45/10/1863) 
µ7KH+\GUR9DSRXU%DWK¶ 
1849 Marius Pierre Philip 
Bourjeaurd, Surgeon 
1878 (BT 
45/10/1878) 
Elastic pessary (surgical 
instrument). 
1849 Dr Ellis of Sudbrook Park, 
Petersham, Surrey 
1943 (BT 
45/10/1943) 
Graduated glass double action 
aperient [purgative] fountain. 
1849 Francis Taylor, Surgeon 2002 (BT 
45/11/2002) 
Nipple shield. 
1850 Robert Calvert, MD 2327 (BT 
45/12/2327) 
Self-adjusting brace. 
1850 W Culverwell, Surgeon 2472 (BT 
45/13/2472) 
Portable domestic vapour bath. 
1850 William Curtis Hugman, 
Surgeon 
2515 (BT 
45/13/2515) 
Portable folding truss. 
1851 Louis Foucart, MD 2742 (BT 
45/14/2742) 
Chest expander or spinal rectifier. 
1851 James Augustus Drake, 
Surgeon 
2921 (BT 
45/15/2921 
An instrument to be used in the 
case of prolapsus uteri. 
1854 William John Clapp, 
Dentist & Medical Student 
and George Fast, Surgeon 
3617 (BT 
45/19/3617) 
Clapp and Fast's tourniquet and 
compress for medical and surgical 
purposes. 
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1867 William Dale, MD 4914 (BT 
45/25/4914) 
Sulphur fumigator. 
1870 John Eldridge Spratt 5136 (BT 
45/26/5136) 
'U6SUDWW¶VLQJXLQDOKernia and 
scrotal bandage. 
1871 James Williams, Doctor of 
Medicine 
5307 (BT 
45/27/5307)  
Inhaler and fomenting and 
disinfecting apparatus. 
1873 Robert Harvey Hilliard, 
MD 
5474 (BT 
45/27/5474) 
Pocket clinical thermometer.  
1874 Robert Harvey Hilliard, 
MD 
5612 (BT 
45/28/5612) 
The pen vaccinator. 
1879 Robert Lee M D 6124 (BT 
45/29/6124) 
An inhaler. 
1881 Dr Ward Cousins 6428 (BT 
45/30/6428) 
Ear protector. 
1881 Dr John Ward Cousins 6468 (BT 
45/30/6468) 
µ7KHVDIHW\K\SRGHUPLFLQMHFWRU¶ 
1883 John Ward Cousins MD 6603 (BT 
45/30/6603) 
Safety pin. 
1883 Dr JA Fleming 6707 (BT 
45/30/6707) 
A flexible electrode [catalogued 
E\WKH2IILFHXQGHUµ6XUJLFDODQG
0HGLFDO,QVWUXPHQWV¶@. 
1883 John Ward Cousins MD 6715 (BT 
45/30/6715) 
Flexible surgical needle. 
1883 Dr J A Fleming 6718 
(BT45/30/6718) 
Medical battery. 
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Appendix B: 
Year Proprietor Patent Number95  Description 
1795 James Wilson 2070 Mode of preventing effects of 
moisture on the human body. 
1797 Timothy Sheldrake 2157 New invented method of curing 
all the deformities of children. 
1798 Benjamin Douglas Perkins 2221 Discovery of a certain art of 
relieving and curing a variety 
RI«E\GUDZLQJRYHUWKHSDUWV
DIIHFWHG«YDULRXVSDLQWHGmetals. 
1802 Joseph Barreto and Mary 
Barreto 
2644 A new method of treating and 
curing ruptures.   
1802 Dr William Beer  2667 New and improved medicines and 
methods of administering the 
same. 
1818 Thomas Machell, Surgeon 
 
 
4288 An improved method of applying 
for medical purposes, the agency 
of atmospheric air, liquid or 
gaseous substances to the external 
VXUIDFH«RIWKHKXPDQERG\. 
1824 John Vallance 5001 Improved method or methods of 
producing intense 
FROG«SURGXFWLYHRIDGYDQWDJHRXV
HIIHFWV«ZKHWKHUmedical, etc.   
1826 Charles Whitlaw, medical 
botanist 
5336 An improvement or improvements 
in administering medicine by the 
agency of steam or vapour. 
1828 John James Watt, surgeon 5643 Application of chlorine to the 
genital organs of both sexes after 
impure sexual intercourse. 
1836 Julius Jeffreys  6988 Improvements in curing or 
relieving disorders of the lungs. 
1846 Moses Poole 
 
11503 Means and apparatus for 
administering certain matter to the 
lungs for medical and surgical 
purposes. 
1848 Pierre Armande Lecomte 
de Fontaine Moreau 
12385 Hygienic apparatus and process 
for curing disease. 
1848 Charles Meinig 12847 Certain improved modes or 
methods of applying galvanism 
and magnetism to curative and 
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sanatory [sic] purposes. 
1853 (GZDUG2¶&RQQHOO 987 Improvements in the mode or 
method of feeding infants or 
invalids. 
1854 Pierre Athonasa Roguier 1763  A new mode of treating and 
curing varicose veins of the 
human body (provisional). 
1855 Henry Holmes, Doctor of 
Medicine and Surgeon 
834 Certain processes of treating the 
human body by gases, vapors and 
electricity (provisional). 
1855 William Peter Piggott, 
Medical Galvanist  
2528 Improvements in galvanic, 
electric and electromagnetic 
apparatus, and in the mode of 
applying the same as a curative 
and remedial agent (provisional). 
1857 Robert Jackson, Gentleman 2056 Improvements in protecting 
certain parts of the body from 
disfigurement in cutaneous 
diseases. 
1857 William Alexander Clarke, 
Hydropathist and 
Thermopathist 
2154 Improvements in the construction 
of and mode of applying hot air 
and vapour baths. 
1857 James Darsie Morrison, 
Dentist 
3189 Improvements in effecting 
surgical and medical operations 
by the agency of artificially 
induced anaesthesia. 
1858 Manuel Leopold Jonas 
Lavater, Rubber 
Manufacturer  
23 The application of the principle of 
exhausting air, as used for...breast 
puPSV«SURYLVLRQDO). 
1858 Gallard Auguste 1712 A new system of trusses 
(provisional). 
1858 Hyacinthe Tertian-Moret  2452 The application of a mineral 
QDPHGGHWHUVRDVD«FXUDWLYH
powder. 
1859 John Lewis Prichard, 
Chemist 
2449 A new method of relieving pain in 
the human body. This consists in 
the use of alleviative drugs in 
combination with a battery to act 
upon the various parts of the 
human body wherein pain may be 
seated.  
1860 Thomas Welton & Edward 
Henry Cradock Monckton 
2820 Improvements in the application 
of electricity or magnetism to the 
human body. 
1862 James Hillert Perry, 1541 An improved method of curing 
29 
 
Gentleman diseases of the human body by 
magnetism. 
1862 William Sadler Kennedy 2806 An improved method of and 
apparatus for applying 
fomentations and other external 
remedies to the throat. 
1863 John Morgan, Fellow of 
the Royal College of 
Surgeons of Ireland 
412 Improvements in embalming and 
preserving from decay human 
bodies, and bodies of other 
animals. 
1864 Amelie Angelina Bonnet 1784 Certain improvements in the 
mode of preparing and applying 
chemical fumigations to the 
treatment of human diseases, and 
in apparatus connected therewith. 
1864 Doctor Jules Guerin of 
Paris 
2842 Means or appliances for treating 
bodily injuries, affections and 
disorders, when atmospheric air is 
to be excluded from the part 
affected.   
1866 William Hibbert 169 Improvements in the combination 
of chemical matters and 
mechanical apparatus applied 
therewith for the prevention or 
cure of contagious and other 
diseases. 
1866 William Temple Cooper, 
Pharmaceutical Chemist 
899 Improvements in the treatment for 
the cure of the venereal disease in 
the male sex (provisional). 
1869 Thomas Welton 1388 A new method of applying 
oxygenated and other gas charged 
charcoal for curative and other 
purposes. 
1869 John Rehse  2190 An improved system for the cure 
of stammering. 
1870 Alfred Manks Mort, 
Chemist 
308 Use of honey soap and resin as a 
special method of medical 
treatment (provisional).  
1870 C Harrison 1635 Administering electricity 
(provisional). 
1874 WP Lyon 1954 A method of applying magnetism 
for curative and other purposes.  
1899 Charles M Johnson 22862 Improved means for destroying 
disease germs.  
 
